13F Filings History of BENDER ROBERT & ASSOCIATES

Portfolio snapshot
Form 13F summary
BENDER ROBERT & ASSOCIATES Form 13F history summarizes the manager's parsed U.S.-listed equity disclosures. Form 13F is generally due within 45 days after each calendar quarter ends. BENDER ROBERT & ASSOCIATES reported 45 equity holdings with a total reported market value of $416,893,878 for Q1 2026. Top reported holdings included NVDA, AAPL, ISRG, AMZN, and META.
Manager identity
Signature and title
Robert Bender - President
Location
Pasadena, CA

Follow Filing Activity

Follow BENDER ROBERT & ASSOCIATES and return when a new 13F portfolio filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q1 2026
Latest value
$416,893,878
Quarter delta
-$64,422,269
Accepted
22 Apr 2026, 19:47
Rows shown
1-25 of 50
Quarter Holdings Reported value Bought Sold Net Top Holdings Form Type Filing Time
Q1 2026 45 $416,893,878 +$5,343,687 -$21,341,836 -$15,998,149 NVDA, AAPL, ISRG, AMZN, META 13F-HR 22 Apr 2026, 19:47
Q4 2025 39 $481,316,147 +$11,964,760 -$14,325,398 -$2,360,638 NVDA, AAPL, ISRG, AMZN, META 13F-HR 28 Jan 2026, 21:44
Q3 2025 46 $462,609,506 +$840,073 -$8,097,320 -$7,257,247 NVDA, AAPL, ISRG, AMZN, MELI 13F-HR 22 Oct 2025, 12:13
Q2 2025 46 $448,323,425 +$1,557,796 -$6,906,062 -$5,348,266 NVDA, AAPL, ISRG, MELI, AMZN 13F-HR 24 Jul 2025, 15:39
Q1 2025 40 $396,107,149 +$34,101,348 -$12,462,878 +$21,638,470 AAPL, NVDA, ISRG, AMZN, MELI 13F-HR 18 Apr 2025, 17:04
Q4 2024 46 $414,294,246 +$4,353,333 -$83,984,734 -$79,631,401 NVDA, AAPL, ISRG, AMZN, META 13F-HR 07 Feb 2025, 17:08
Q3 2024 39 $470,926,521 +$470,926,521 $0 +$470,926,521 AAPL, NVDA, ISRG, AMZN, MELI 13F-HR 30 Oct 2024, 11:18
Q2 2024 0 $0 $0 -$426,692,920 -$426,692,920 13F-HR 30 Jul 2024, 17:27
Q1 2024 43 $426,692,920 +$457,924 -$9,429,806 -$8,971,882 AAPL, NVDA, ISRG, AMZN, META 13F-HR 22 Apr 2024, 19:47
Q4 2023 50 $396,775,142 +$1,333,247 -$3,117,779 -$1,784,532 AAPL, NVDA, ISRG, LULU, AMZN 13F-HR 31 Jan 2024, 15:51
Q3 2023 48 $342,212,147 +$582,686 -$3,702,104 -$3,119,418 AAPL, NVDA, ISRG, LULU, AMZN 13F-HR 13 Oct 2023, 21:17
Q2 2023 50 $362,128,559 +$9,577,822 -$14,444,480 -$4,866,658 AAPL, NVDA, ISRG, LULU, AMZN 13F-HR 13 Jul 2023, 21:35
Q1 2023 55 $322,933,040 +$2,808,391 -$2,708,526 +$99,865 AAPL, ISRG, NVDA, LULU, MELI 13F-HR 20 Apr 2023, 21:41
Q4 2022 48 $267,433,741 +$543,182 -$5,110,446 -$4,567,264 AAPL, ISRG, LULU, AMZN, ULTA 13F-HR 02 Feb 2023, 10:09
Q3 2022 54 $258,241,000 +$19,442,073 -$1,734,507 +$17,707,566 AAPL, AMZN, ISRG, LULU, MELI 13F-HR 26 Oct 2022, 18:25
Q2 2022 55 $261,549,000 +$17,772,366 -$3,795,446 +$13,976,920 AAPL, ISRG, AMZN, LULU, NVDA 13F-HR 18 Jul 2022, 21:09
Q1 2022 45 $351,083,000 +$13,039,579 -$4,381,682 +$8,657,897 AAPL, ISRG, AMZN, LULU, NVDA 13F-HR 14 Apr 2022, 16:50
Q4 2021 46 $188,155,000 $0 -$2,806,000 -$2,806,000 AMZN, LULU, ILMN, META, ADBE 13F-HR 04 Feb 2022, 19:02
Q3 2021 49 $349,337,000 +$19,176,137 -$11,894,484 +$7,281,653 AAPL, ISRG, AMZN, LULU, MELI Restatement 08 Nov 2021, 20:48
Q2 2021 47 $351,934,000 +$7,101,131 -$6,410,723 +$690,408 AAPL, ISRG, AMZN, ILMN, MELI 13F-HR 16 Jul 2021, 16:54
Q1 2021 56 $310,814,000 +$13,443,112 -$1,114,559 +$12,328,553 AAPL, AMZN, ISRG, MELI, ILMN 13F-HR 28 Apr 2021, 08:21
Q4 2020 47 $307,459,000 +$2,881,784 -$2,693,265 +$188,519 AAPL, ISRG, AMZN, MELI, LULU 13F-HR 29 Jan 2021, 10:51
Q3 2020 46 $271,695,000 +$42,378,415 -$4,063,077 +$38,315,338 AAPL, AMZN, ISRG, LULU, MELI 13F-HR 28 Oct 2020, 20:43
Q2 2020 46 $244,813,000 +$2,779,548 -$5,656,113 -$2,876,565 AAPL, AMZN, LULU, ISRG, ILMN 13F-HR 31 Jul 2020, 15:06
Q1 2020 45 $180,921,000 +$337,190 -$3,151,782 -$2,814,592 AAPL, ISRG, AMZN, ILMN, LULU 13F-HR 21 Apr 2020, 12:48
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .